[A comparative evaluation of parenteral and oral preparations of gold and D-penicillamine in the treatment of rheumatoid nephropathy].
Analysis is made of the results of the treatment with parenteral (crysanol and myochrysine) and oral (ridaura) gold drugs as well as with small doses of D-penicillamine (DP) of patients suffering from rheumatoid arthritis with the signs of nephropathy. The latter ones were identified, respectively, in 18 out of 80 patients who began receiving treatment, in 17 out of 72, and in 16 out of 61 patients. The clinical, laboratory, instrumental and morphological manifestations of nephropathy are described and analysis of their dynamics under the treatment impact is provided. It is noted that these types of basic therapy produce a beneficial effect on the manifestations of rheumatoid nephropathy. That referred to a greater measure to the gold drugs than to the small doses of DP. The degree of counteracting the symptoms of renal pathology agreed well with a good clinical effect in respect to the articular syndrome and inflammatory responses of blood. Among patients receiving crysanol, iatrogenic nephropathy was recorded in 8.75% of cases, among those on ridaura, in 2.8%, and those on DP, in 8.2% of cases. The authors provide evidence for the use of gold drugs and DP in patients suffering from rheumatoid nephropathy.
Chichasova
N V
NV
Kanevskaia
M Z
MZ
Slobodina
G A
GA
Varshavskiĭ
V A
VA
Krel'
O V
OV
Krel'
A A
AA
D000284:Administration, Oral; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D001310:Auranofin / Q000008:administration & dosage; D004112:Dimercaprol / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006052:Gold Sodium Thiomalate / Q000008:administration & dosage; D006801:Humans; D007267:Injections; D007674:Kidney Diseases / Q000188:drug therapy / Q000209:etiology; D050607:Organogold Compounds; D009942:Organometallic Compounds / Q000008:administration & dosage; D010396:Penicillamine / Q000008:administration & dosage*; D020005:Propanols; D011446:Prospective Studies; D013438:Sulfhydryl Compounds; D013997:Time Factors
D018501:Antirheumatic Agents; D050607:Organogold Compounds; D009942:Organometallic Compounds; D020005:Propanols; D013438:Sulfhydryl Compounds; D004112:Dimercaprol; D006052:Gold Sodium Thiomalate; D001310:Auranofin; C013394:aurotioprol; D010396:Penicillamine
Sravnitel'naia otsenka parenteral'nykh i oral'nykh preparatov zolota i D-penitsillamina v lechenii revmatoidnoĭ nefropatii.